A Validated Scale for Assessing the Severity of Acute Infectious Mononucleosis.
chronic fatigue syndrome
hospitalization
infectious mononucleosis
severity of mononucleosis
steroids
Journal
The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
19
11
2018
revised:
14
01
2019
accepted:
17
01
2019
pubmed:
12
3
2019
medline:
17
4
2020
entrez:
12
3
2019
Statut:
ppublish
Résumé
To develop a scale for the severity of mononucleosis. One to 5 percent of college students develop infectious mononucleosis annually, and about 10% meet criteria for chronic fatigue syndrome (CFS) 6 months following infectious mononucleosis. We developed a severity of mononucleosis scale based on a review of the literature. College students were enrolled, generally when they were healthy. When the students developed infectious mononucleosis, an assessment was made as to the severity of their infectious mononucleosis independently by 2 physicians using the severity of mononucleosis scale. This scale was correlated with corticosteroid use and hospitalization. Six months following infectious mononucleosis, an assessment is made for recovery from infectious mononucleosis or meeting 1 or more case definitions of CFS. In total, 126 severity of mononucleosis scales were analyzed. The concordance between the 2 physician reviewers was 95%. All 3 hospitalized subjects had severity of mononucleosis scores ≥2. Subjects with severity of mononucleosis scores of ≥1 were 1.83 times as likely to be given corticosteroids. Students with severity of mononucleosis scores of 0 or 1 were less likely to meet more than 1 case definition of CFS 6 months following infectious mononucleosis. The severity of mononucleosis scale has interobserver, concurrent and predictive validity for hospitalization, corticosteroid use, and meeting criteria for CFS 6 months following infectious mononucleosis.
Identifiants
pubmed: 30853204
pii: S0022-3476(19)30123-4
doi: 10.1016/j.jpeds.2019.01.035
pmc: PMC6535355
mid: NIHMS1519317
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
130-133Subventions
Organisme : NIAID NIH HHS
ID : R01 AI105781
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
Am J Med. 2000 Nov;109(7):531-7
pubmed: 11063953
J Microbiol Immunol Infect. 2005 Aug;38(4):255-61
pubmed: 16118672
J Infect Dis. 2005 Nov 1;192(9):1505-12
pubmed: 16206064
J Infect Dis. 2006 Mar 1;193(5):664-71
pubmed: 16453261
J Clin Microbiol. 2006 May;44(5):1873-4
pubmed: 16672427
BMJ. 2006 Sep 16;333(7568):575
pubmed: 16950834
South Med J. 1977 Apr;70(4):437-9
pubmed: 191934
Pediatrics. 2009 Jul;124(1):189-93
pubmed: 19564299
Clin Infect Dis. 2010 Mar 1;50(5):699-706
pubmed: 20121570
Arch Pediatr Adolesc Med. 2011 Aug;165(8):765-6
pubmed: 21810640
Health Psychol Behav Med. 2014 Jan 1;2(1):41-51
pubmed: 24660116
Can J Infect Dis Med Microbiol. 2014 Sep;25(5):277-80
pubmed: 25371691
Mil Med. 2015 Jul;180(7):721-3
pubmed: 26126237
J Diagn Tech Biomed Anal. 2016 Jun;5(1):null
pubmed: 27583306
Ann Intern Med. 1994 Dec 15;121(12):953-9
pubmed: 7978722
Br J Psychiatry. 1998 Dec;173:475-81
pubmed: 9926075